Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NVSEF - Poseida Therapeutics Begins IPO Effort

NVSEF - Poseida Therapeutics Begins IPO Effort

Novartis Ag Basel Akt

Quick Take

Poseida Therapeutics (PSTX) has filed to raise $115 million in an IPO of its common stock, according to an S-1 registration statement.

The firm is advancing a broad pipeline of genetic and CAR-T-based therapies for blood, solid, and other cancers.

PSTX has achieved promising early-stage trial results for its co-lead candidates.

I'll provide an update when we learn more about the IPO from management.

Company & Technology

San Diego, California-based Poseida was founded to develop CAR-T and Cas-CLOVER genetic therapy approaches to treating cancers and other cancers.

Management is headed

Read more ...
Stock Information
Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com
Menu
NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...